Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis

Clin Chest Med. 2004 Mar;25(1):133-40. doi: 10.1016/S0272-5231(03)00139-4.

Abstract

Current and past drug intake is essential in the evaluation of a patient who has DAH. Simple treatments, such as reversal of a coagulation defect or withdrawal of the drug, can reverse a life-threatening situation. DAO may result in DAH, and depending on the severity of the drug withdrawl, will not be adequate and corticosteroid therapy is recommended.

Publication types

  • Review

MeSH terms

  • Anticoagulants / adverse effects
  • Fibrinolytic Agents / adverse effects
  • Hemorrhage / chemically induced*
  • Humans
  • Iatrogenic Disease
  • Lung Diseases / chemically induced*
  • Vasculitis / chemically induced*

Substances

  • Anticoagulants
  • Fibrinolytic Agents